Open Forum

At Children's Health in Dallas, we are currently working to refine our inclusion and exclusion criteria across our infusion center sites.

We operate three distinct infusion settings:

• One infusion center located within our main hospital, which primarily serves our hematology/oncology population
• Two ambulatory infusion centers:
  • One situated in our Specialty Center, which is geographically separate from the main hospital and therefore does not fall under EMTALA requirements; emergencies are managed via 911
  • A second ambulatory infusion center located within our Plano (North Dallas) hospital campus

With the rapid expansion of new drug therapies, we see an opportunity to clearly define which treatments are most appropriate for each location based on available resources, acuity, and support capabilities.

We would appreciate learning from others who have already addressed this challenge. Specifically, does anyone have established infusion center inclusion/exclusion criteria or decision frameworks that they would be willing to share? We are hoping to leverage existing best practices rather than reinvent the wheel.

Thank you in advance for any insights or resources you can provide.